SIGLEC1 and bacterial infectious disease: In addition to these two bacterial infections, the CD169 molecule has been shown to function as a receptor for bacterial uptake of pathogens rich in sialylated polysaccharides, such as Neisseria meningitidis, Campylobacter jejuni, and Trypanosoma cruzi (124–126).